NCT02120807 2023-01-26
Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
Memorial Sloan Kettering Cancer Center
Innovent Biologics (Suzhou) Co. Ltd.
National Cancer Institute (NCI)
National Cancer Institute (NCI)